Valuation: Guerbet

Market Cap 104M 121M 97.73M 89.26M 168M 11.51B 171M 1.15B 449M 5.76B 453M 443M 19.2B P/E 2026 *
-4.64x
P/E 2027 * 9.01x
Enterprise Value 480M 554M 449M 410M 771M 52.89B 785M 5.27B 2.06B 26.46B 2.08B 2.03B 88.26B EV / Sales 2026 *
0.63x
EV / Sales 2027 * 0.59x
Free-Float
36.58%
Yield 2026 *
-
Yield 2027 * 2.82%
1 day+0.12%
1 week+3.50%
Current month+2.73%
1 month-5.15%
3 months-21.59%
6 months-41.53%
Current year-42.10%
1 week 7.86
Extreme 7.86
8.53
1 month 7.43
Extreme 7.43
9.28
Current year 7.43
Extreme 7.43
15.12
1 year 7.43
Extreme 7.43
23.1
3 years 7.43
Extreme 7.43
40.25
5 years 7.43
Extreme 7.43
45.65
10 years 7.43
Extreme 7.43
90.64
Manager TitleAgeSince
Chief Executive Officer - 01/02/2026
Chief Executive Officer - 21/09/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 44 28/05/2015
Director/Board Member 50 18/05/2017
Director/Board Member 51 21/11/2023
Date Insider Type Main position Quantity % Market Cap.
13/11/25 Buy

Director

1,100 0.0087%
13/11/25 Buy

Director

90 0.0007%
10/10/25 Buy

Director

200 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
+0.12%+3.50%-60.38%-60.29% 121M
-1.43%-4.60%-15.00%-17.72% 13.7B
+3.19%+12.90%+48.02%+1.84% 4.2B
+0.29%-0.05%-38.04%-52.18% 1.29B
-1.04%-5.24%-35.03%-39.61% 1.2B
-1.47%-2.86%+27.18%+87.36% 1.15B
-1.10%+1.19%-43.84% - 983M
+0.17%+35.30%+53.15%+157.44% 616M
-1.20%-7.95%+67.94% - 334M
-1.16%-0.26%-60.02%+275.86% 265M
Average -0.36%+15.78%-5.60%+44.09% 2.39B
Weighted average by Cap. -0.44%+4.92%-3.11%-3.83%

Financials

2026 *2027 *
Net sales 764M 882M 715M 653M 1.23B 84.15B 1.25B 8.39B 3.28B 42.1B 3.31B 3.24B 140B 798M 921M 747M 682M 1.28B 87.94B 1.3B 8.77B 3.43B 44B 3.46B 3.38B 147B
Net income -35.8M -41.32M -33.49M -30.59M -57.53M -3.94B -58.51M -393M -154M -1.97B -155M -152M -6.58B 8.3M 9.58M 7.77M 7.09M 13.34M 914M 13.57M 91.18M 35.67M 457M 35.96M 35.18M 1.53B
Net Debt 376M 434M 351M 321M 604M 41.38B 614M 4.13B 1.61B 20.7B 1.63B 1.59B 69.06B 370M 427M 346M 316M 595M 40.8B 605M 4.07B 1.59B 20.41B 1.6B 1.57B 68.09B
Logo Guerbet
Guerbet is a European leader in producing and selling contrast products for medical imaging. The group's products make it possible to visualize different organs and the lymphatic and vascular systems of the human body by making them opaque. Net sales break down by product family as follows: - X-ray imaging products (54.4%); - MRI products (32.1%); - other (13.5%): contrast products for echography and nuclear medicine, fine chemicals products. At the end of 2024 the group had 8 production sites located in France (4), the United States (2), Ireland and Brazil. Net sales are distributed geographically as follows: Europe/Middle East/Africa (43.8%), Americas (29.7%) and Asia (26.5%).
Employees
2,700
Date Price Change Volume
11/08/26 €8.280 +0.12% 4,256
10/08/26 €8.270 -0.36% 3,051
07/08/26 €8.300 +0.73% 9,303
06/08/26 €8.240 +2.23% 24,249
05/08/26 €8.060 +0.75% 9,525
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
3
Last Close Price
8.280EUR
Average target price
8.433EUR
Spread / Average Target
+1.85%

Quarterly revenue - Rate of surprise